Recent Company News

• 02:46 AM ET Apr 30, 2025
  

  Medipal Holdings increases forecast for year-end dividend to JPY32/sh vs prior guidance JPY30/sh (¥2427.5000, 0)

• 11:42 PM ET Apr 08, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (275 total)

• 11:28 PM ET Apr 06, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (102 total)

• 01:43 AM ET Feb 10, 2025
  

  Medipal Holdings reports 9M net income attributable ¥56.71B, +13% vs year-ago ¥50.24B (¥2232.0000, 0)

• 06:25 PM ET Dec 05, 2024
  

  Medipal Holdings to acquire 20% stake in Teva Takeda Pharma (¥2405.5000, 0)

• 02:12 AM ET Dec 03, 2024
  

  JCR, MEDIPAL initiate first dosing in phase I/II clinical trial of JR-446 for Mucopolysaccharidosis Type IIIB in Japan (¥727.0000, 0)

• 02:12 AM ET Nov 01, 2024
  

  Medipal Holdings reports H1 net income attributable ¥21.73B, +27% vs year-ago ¥17.15B

• 06:13 AM ET Sep 19, 2024
  

  Medipal Holdings downgraded to hold from buy at Jefferies (¥2554.5000, 0)

• 02:11 AM ET Sep 02, 2024
  

  Medipal Holdings completes up-to-¥5B buyback (¥2554.5000, 0)

• 02:09 AM ET Aug 01, 2024
  

  Medipal Holdings reports Q1 net income attributable ¥9.01B vs FactSet ¥9.27B [2 est, ¥9.13-9.40B] (¥2672.5000, 0)